Abstract
Aim of work To determine whether talosin A inhibits production of pro-inflammatory cytokines and nitric oxide (NO) in lipopolysaccharide (1 μg/ml)-stimulated RAW 264.7 macrophages. Talosin A (10 and 50 μg/ml) significantly reduced LPS-induced overproduction of tumor necrosis factor-α, interleukin IL-1β, -6 and NO in a dose-dependent manner (P < 0.01). Talosin A had a direct NO-scavenging activity in the cell-free system. In RT-PCR analysis, gene expressions were inhibited at a transcriptional level. Moreover, the activation of nuclear factor-kappa B (NF-κB) was significantly suppressed by talosin A in LPS-stimulated macrophage cells (P < 0.05). Therefore, we confirmed anti-inflammatory activity of talosin A was via suppression of pro-inflammatory cytokines, NO production and NF-κB activation, suggesting a therapeutic candidate for inflammatory disorders.
Similar content being viewed by others
References
Alderton WK, Cooper CE, Knowles RG (2001) Nitric oxide synthases: structure, function and inhibition. Biochem J 357:593–615
Alley MC, Scudiero DA, Monks A, Hursey ML, Czerwinski MJ, Fine DL, Abbott BJ, Mayo JG, Shoemaker RH, Boyd MR (1998) Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res 48:589–601
Barsness KA, Arcaroli J, Harken AH, Abraham E, Banerjee A, Reznikov L, McIntyre RC (2004) Hemorrhage-induced acute lung injury is TLR-4 dependent. Am J Physiol Regul Integr Comp Physiol 287:592–599
Cherng SC, Cheng SN, Tarn A, Chou TC (2007) Anti-inflammatory activity of c-phycocyanin in lipopolysaccharide-stimulated RAW 264.7 macrophages. Life Sci 81:1431–1435
Cogswell JP, Godlevski MM, Wisely GB, Clay WC, Leesnitzer LM, Ways JP, Gray JG (1994) NF-kappa B regulates IL-1 beta transcription through a consensus NF-kappa B binding site and a nonconsensus CRE-like site. J Immuno 153:712–723
Emre Y, Hurtaud C, Nubel T, Criscuolo F, Ricquier D, Cassard-Doulcier AM (2007) Mitochondria contribute to LPS-induced MAPK activation via uncoupling protein UCP2 in macrophages. Biochem J 402:271–278
Fujiwara N, Kobayashi K (2005) Macrophages in inflammation. Curr Drug Targets Inflamm Allergy 4:281–286
Ghezzi P, Cerami A (2005) Tumor necrosis factor as a pharmacological target. Mol Biotechnol 31:239–244
Gottstein N, Ewins BA, Eccleston C, Hubbard GP, Kavanagh IC, Minihane AM, Weinberg PD, Rimbach G (2003) Effect of genistein and daidzein on platelet aggregation and monocyte and endothelial function. Br J Nutr 8:607–616
Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR (1982) Analysis of nitrate, nitrite, and [15 N] nitrate in biological fluids. Anal Biochem 126:131–138
Guha M, Mackman N (2001) LPS induction of gene expression in human monocytes. Cell Signal 13:85–94
Hamalainen M, Nieminen R, Vuorela P, Heinonen M, Moilanen E (2007) Anti-inflammatory effects of flavonoids: genistein, kaempferol, quercetin, and daidzein inhibit STAT-1 and NF-kappaB activations, whereas flavone, isorhamnetin, naringenin, and pelargonidin inhibit only NF-kappaB activation along with their inhibitory effect on iNOS expression and NO production in activated macrophages. Mediators Inflamm 45673
Hussain SP, Hofseth LJ, Harris CC (2003) Radical causes of cancer. Nature Rev Cancer 3:276–285
Jean-Baptiste E (2007) Cellular mechanisms in sepsis. J Intensive Care Med 22:63–72
Kao TH, Chen BH (2006) Functional components in soybean cake and their effects on antioxidant activity. J Agri Food Chem 54:7544–7555
Kao TH, Wu WM, Hung CF, Wu WB, Chen BH (2007) Anti-inflammatory effects of isoflavone powder produced from soybean cake. J Agri Food Chem 55:11068–11079
Landino LM, Crews BC, Timmons MD, Morrow JD, Marnett LJ (1996) Peroxynitrite, the coupling product of nitric oxide and superoxide, activates prostaglandin biosynthesis. Proc Natl Acad Sci USA 93:15069–15074
Lee HJ, Hyun EA, Yoon WJ, Kim BH, Rhee MH, Kang HK, Cho JY, Yoo ES (2006) In vitro anti-inflammatory and anti-oxidative effects of Cinnamomum camphora extracts. J Ethnopharmacol 103:208–216
Lim S, Kang KW, Park SY, Kim SI, Choi YS, Kim ND, Lee KU, Lee HK, Pak YK (2004) Inhibition of lipopolysaccharide-induced inducible nitric oxide synthase expression by a novel compound, mercaptopyrazine, through suppression of nuclear factor-kappaB binding to DNA. Biochem Pharmacol 68:719–728
Lowe JB (2003) Glycan-dependent leukocyte adhesion and recruitment in inflammation. Curr Opin Cell Biol 15:531–538
Merx MW, Weber C (2007) Sepsis and the heart. Circulation 116:793–802
Moochhala S, Rajnakova A (1999) Role of nitric oxide in cancer biology. Free Radic Res 31:671–679
Renard P, Ernest I, Houbion A, Art M, Le Calvez H, Raes M, Remacle J (2001) Development of a sensitive multi-well colorimetric assay for active NFkappaB. Nucleic Acids Res 29:E21
Sreejayan, Rao MN (1997) Nitric oxide scavenging by curcuminoids. J Pharm Pharmacol 49:105–107
Tak PP, Firestein GS (2001) NF-kappaB: a key role in inflammatory diseases. J Clin Invest 107:7–11
Vila-del Sol V, Diaz-Munoz MD, Fresno M (2007) Requirement of tumor necrosis factor alpha and nuclear factor-kappaB in the induction by IFN-gamma of inducible nitric oxide synthase in macrophages. J Leukoc Biol 81:272–283
Wietrzyk J, Grynkiewicz G, Opolski A (2005) Phytoestrogens in cancer prevention and therapy––mechanisms of their biological activity. Anticancer Res 25:2357–2366
Yoon TM, Kim JW, Kim JG, Kim WG, Suh JW (2006) Talosins A and B: new isoflavonol glycosides with potent antifungal activity from Kitasatospora kifunensis MJM341. I. Taxonomy, fermentation, isolation, and biological activities. J Antibiot (Tokyo) 59:633–639
Acknowledgement
This work was partially supported by a grant code #200702186 from the BioGreen 21 Program, Rural Development Administration, the Republic of Korea.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hwang, YH., Kim, MS., Song, IB. et al. Anti-inflammatory effects of talosin A via inhibition of NF-kappaB activation in lipopolysaccharide-stimulated RAW264.7 cells. Biotechnol Lett 31, 789–795 (2009). https://doi.org/10.1007/s10529-009-9943-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10529-009-9943-2